European equities traded in the US as American depositary receipts started the week higher on Monday, rising 0.45% to 1,928.13 on the S&P Europe Select ADR Index.

From continental Europe, the gainers from biotech firm BioNTech (BNTX) and Banco Santander (SAN), which advanced 2.1% and 1.7% respectively. They were followed by lenders Banco Bilbao Vizcaya Argentaria (BBVA) and ING (ING), which increased 1.5% and 1.3% respectively.

The decliners from continental Europe were led by pharmaceutical firm Novo Nordisk (NVO) and accommodations booking site trivago (TRVG), which dropped 8% and 3.8% respectively. They were followed by petroleum refiner Equinor (EQNR) and biopharmaceutical company Cellectis (CLLS), which lost 2.7% and 1.3% respectively.

The gainers from the UK were led by Akari Therapeutics (AKTX) and software firm Endava (DAVA), which rose 4% and 3.6%, respectively. They were followed by pharmaceutical companies GSK (GSK) and AstraZeneca (AZN), which were up 1.5% and 1.2% respectively.

The decliners from the UK and Ireland were led by oil and gas company BP (BP) and Biodexa Pharmaceuticals (BDRX), which fell 2.1% and 1.5% respectively. They were followed by mining company BHP Group (BHP) and oil and gas company Shell (SHEL), which were down 0.9% and 0.8% respectively.